产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 25140 | Revumenib | 2169919-21-3 | 98% Min. |  |
| Revumenib, also known as SNDX-5613, is a potent and specific Menin-MLL inhibitor. It | ||||
| 25125 | Radiprodil | 496054-87-6 | 98% Min. |  |
| Radiprodil, also known as RGH-896, is an orally active and selective NMDA receptors a | ||||
| 25124 | Radiprodil | 496054-87-6 | 98% Min. | |
| Radiprodil, also known as RGH-896, is an orally active and selective NMDA receptors a | ||||
| 25106 | Rilzabrutinib | 1575596-29-0 | 98% Min. |  |
| Rilzabrutinib, also known as PRN1008, is a reversible covalent, selective and oral ac | ||||
| 25100 | Rimiducid | 195514-63-7 | 98% Min. |  |
| Rimiducid, also known as AP1903, is a lipid-permeable bivalent "dimerizer" | ||||
| 25091 | Rilzabrutinib ( PRN1008 ) | 1575591-66-0 | ≧98.0% | _1575591-66-0.png) |
| Rilzabrutinib ( PRN1008 ) 是一种口服、可逆、共价的布鲁顿酪氨酸激酶 | ||||
| 25084 | Ronopterin | 206885-38-3 | 98% Min. |  |
| Ronopterin is a potent Nitric oxide synthase inhibitor and Neuroprotectant. | ||||
| 25074 | RMC-6236 | 2765081-21-6 | 98% Min. |  |
| Daraxonrasib, also known as RMC-6236 and RAS-IN-2, is a potent and selective RAS(ON) | ||||
| 25068 | Roginolisib | 1305267-37-1 | 98% Min. |  |
| Roginolisib, also known as MSC2360844 and IOA-244, is a potent, orally active and sel | ||||
| 25050 | Reparixin | 266359-83-5 | 98% Min. |  |
| Reparixin is an inhibitor of CXCR2 function, which attenuates inflammatory responses | ||||
| 25038 | (R)-2-(3,5-二氟苯基)-2-羟基乙酸 | 794566-88-4 | 98% Min. | -2-(3,5-difluorophenyl)-2-hydroxyacetic_acid_794566-88-4.png) |
| 25035 | Relacorilant | 1496510-51-0 | 98% Min. |  |
| Relacorilant is discontinued. | ||||
| 24148 | RGT-018 | 2794934-49-7 | 98% Min. |  |
| RGT-018 is a potent and orally active SOS1 inhibitor with anti-tumor effects. | ||||
| 24136 | (Rac)-SHIN2 | 2204289-53-0 | 98% Min. | -SHIN2_2204289-53-0.png) |
| (Rac)-SHIN2 is a serine hydroxymethyltransferase (SHMT) inhibitor having 1,4-dihydrop | ||||
| 24130 | (R)-(-)-α-Methylhistamine HBr | 868698-49-1 | 98% Min. | -(-)-α-Methylhistamine_HBr_868698-49-1.png) |
| (R)-(-)-α-Methylhistamine dihydrobromide is a very potent, high affinity H3 agonist | ||||
| 24078 | Risovalisib mesylate | 1494684-33-1 | 98% Min. |  |
| CYH33 (CYH-33) is a novel potent, PI3Kα-selective inhibitor with IC50 of 5.9 nM/598 | ||||
| 20666 | RMC-4998 | 2642037-07-6 | 98% Min. |  |
| RMC-4998 is a tri-complex inhibitor and KRASG12C inhibitor. RMC-4998 targets the acti | ||||
| 24008 | RNK-05047 | 2503036-46-0 | ≧98.0% |  |
| RNK-05047 为BRD4降解剂，其在小鼠荷瘤异种移植模型中展现出显著抑 | ||||
| 20655 | (R)-Praziquantel | 57452-98-9 | 98% Min. | -Praziquantel_57452-98-9.png) |
| (R)-Praziquantel is an active enantiomer of praziquantel that acts as a potent anthel | ||||
| 20652 | Resminostat | 864814-88-0 | 98% Min. |  |
| Resminostat, also known as 4S-201 and RAS2410, is an orally bioavailable inhibitor of | ||||
| 20627 | Resigratinib | 2750709-91-0 | 98% Min. |  |
| Resigratinib is a fibroblast growth factor receptor tyrosine kinase inhibitor and ant | ||||
| 20621 | Risvodetinib | 2031185-00-7 | 98% Min. |  |
| Risvodetinib, also known as IkT-148009., is a brain-penetrant c-Abl inhibitor with a | ||||
| 20595 | Ropidoxuridine | 93265-81-7 | 98% Min. |  |
| Ropidoxuridine is a novel, orally available, thymidine analogue and prodrug for IUdR, | ||||
| 20526 | RPT193 | 2366152-15-8 | 98% Min. |  |
| 230403 | (R,S)-BI 1015550 | 1423719-27-0 | ≧98.0% | -BI_1015550_1423719-27-0.png) |
| BI 1015550 is a novel PDE4 inhibitor showing a preferential enzymatic inhibition of P | ||||
| 233901 | RRX-001 | 925206-65-1 | ≧98.0% |  |
| RRx-001 是一种高选择性 NLRP3 抑制剂，具有血管正常化和肿瘤相关的 | ||||
| 20460 | Ro5-3335 | 30195-30-3 | ≧98.0% |  |
| Ro5-3335 是一种亲脂性小分子 RUNX1 抑制剂。 | ||||
| 20452 | Ritlecitinib tosylate | 2192215-81-7 | 98% Min. |  |
| Ritlecitinib, also known as PF-06651600, is a potent and selective JAK3 inhibitor. PF | ||||
| 2320201 | Ro 24-7429 | 139339-45-0 | ≧98.0% |  |
| Ro24-7429是一种有效的口服活性HIV-1 反式激活蛋白Tat 拮抗剂和一种 | ||||
| 822224 | 布瑞拉沙秦（Brilaroxazine） | 1239729-06-6 | ≧98.0% |  |
| RP-5063（Brilaroxazine） 是一种多模式的血清素和多巴胺受体调节剂， | ||||